Acta Neuropathologica Communications (Apr 2021)

Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma

  • Kathleen M. Schieffer,
  • Alexander Z. Feldman,
  • Esko A. Kautto,
  • Sean McGrath,
  • Anthony R. Miller,
  • Maria Elena Hernandez-Gonzalez,
  • Stephanie LaHaye,
  • Katherine E. Miller,
  • Daniel C. Koboldt,
  • Patrick Brennan,
  • Benjamin Kelly,
  • Amy Wetzel,
  • Vibhuti Agarwal,
  • Margaret Shatara,
  • Suzanne Conley,
  • Diana P. Rodriguez,
  • Rolla Abu-Arja,
  • Ala Shaikhkhalil,
  • Matija Snuderl,
  • Brent A. Orr,
  • Jonathan L. Finlay,
  • Diana S. Osorio,
  • Annie I. Drapeau,
  • Jeffrey R. Leonard,
  • Christopher R. Pierson,
  • Peter White,
  • Vincent Magrini,
  • Elaine R. Mardis,
  • Richard K. Wilson,
  • Catherine E. Cottrell,
  • Daniel R. Boué

DOI
https://doi.org/10.1186/s40478-021-01164-z
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Retinoblastoma is a childhood cancer of the retina involving germline or somatic alterations of the RB Transcriptional Corepressor 1 gene, RB1. Rare cases of sellar-suprasellar region retinoblastoma without evidence of ocular or pineal tumors have been described. A nine-month-old male presented with a sellar-suprasellar region mass. Histopathology showed an embryonal tumor with focal Flexner-Wintersteiner-like rosettes and loss of retinoblastoma protein (RB1) expression by immunohistochemistry. DNA array-based methylation profiling confidently classified the tumor as pineoblastoma group A/intracranial retinoblastoma. The patient was subsequently enrolled on an institutional translational cancer research protocol and underwent comprehensive molecular profiling, including paired tumor/normal exome and genome sequencing and RNA-sequencing of the tumor. Additionally, Pacific Biosciences (PacBio) Single Molecule Real Time (SMRT) sequencing was performed from comparator normal and disease-involved tissue to resolve complex structural variations. RNA-sequencing revealed multiple fusions clustered within 13q14.1-q21.3, including a novel in-frame fusion of RB1-SIAH3 predicted to prematurely truncate the RB1 protein. SMRT sequencing revealed a complex structural rearrangement spanning 13q14.11-q31.3, including two somatic structural variants within intron 17 of RB1. These events corresponded to the RB1-SIAH3 fusion and a novel RB1 rearrangement expected to correlate with the complete absence of RB1 protein expression. Comprehensive molecular analysis, including DNA array-based methylation profiling and sequencing-based methodologies, were critical for classification and understanding the complex mechanism of RB1 inactivation in this diagnostically challenging tumor.

Keywords